CONSUN PHARMA Buys Back 398,000 Shares for HKD 5.09 Million, Boosting Treasury Stock to 2.16 Million Shares

Bulletin Express06-22

On 22 June 2026, CONSUN PHARMA executed an on-market repurchase of 398,000 ordinary shares, according to the company’s Next Day Disclosure Return filed with the Hong Kong Stock Exchange.

The shares were bought at prices ranging between HKD 12.67 and HKD 12.88, translating into a volume-weighted average cost of HKD 12.79 per share and an aggregate consideration of HKD 5.09 million.

After the transaction: • Issued shares (excluding treasury shares) declined by 0.0474% to 839.39 million. • Treasury shares increased to 2.16 million, while total issued shares remained unchanged at 841.55 million because the repurchased shares have not been cancelled.

Repurchase mandate status: • The current mandate, approved on 26 May 2026, authorises the repurchase of up to 84.12 million shares. • Including the latest buyback, 1.82 million shares have been repurchased under this mandate, utilising 2.16% of the authorised limit. • In line with listing rules, CONSUN PHARMA is restricted from issuing new shares or disposing of treasury shares until 22 July 2026.

All repurchases were conducted in compliance with the Main Board Listing Rules, and the company confirmed that all regulatory and corporate approvals were duly obtained.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1166023004?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-22 20:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1166023004","market":"us","top_or_hot":-1,"title":"CONSUN PHARMA Buys Back 398,000 Shares for HKD 5.09 Million, Boosting Treasury Stock to 2.16 Million Shares","media":"Bulletin Express","content":"<p>On 22 June 2026, CONSUN PHARMA executed an on-market repurchase of 398,000 ordinary shares, according to the company’s Next Day Disclosure Return filed with the Hong Kong Stock Exchange.</p>\n<p>The shares were bought at prices ranging between HKD 12.67 and HKD 12.88, translating into a volume-weighted average cost of HKD 12.79 per share and an aggregate consideration of HKD 5.09 million.</p>\n<p>After the transaction:\n• Issued shares (excluding treasury shares) declined by 0.0474% to 839.39 million.  \n• Treasury shares increased to 2.16 million, while total issued shares remained unchanged at 841.55 million because the repurchased shares have not been cancelled.</p>\n<p>Repurchase mandate status:\n• The current mandate, approved on 26 May 2026, authorises the repurchase of up to 84.12 million shares.  \n• Including the latest buyback, 1.82 million shares have been repurchased under this mandate, utilising 2.16% of the authorised limit.  \n• In line with listing rules, CONSUN PHARMA is restricted from issuing new shares or disposing of treasury shares until 22 July 2026.</p>\n<p>All repurchases were conducted in compliance with the Main Board Listing Rules, and the company confirmed that all regulatory and corporate approvals were duly obtained.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CONSUN PHARMA Buys Back 398,000 Shares for HKD 5.09 Million, Boosting Treasury Stock to 2.16 Million Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCONSUN PHARMA Buys Back 398,000 Shares for HKD 5.09 Million, Boosting Treasury Stock to 2.16 Million Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-22 20:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>On 22 June 2026, CONSUN PHARMA executed an on-market repurchase of 398,000 ordinary shares, according to the company’s Next Day Disclosure Return filed with the Hong Kong Stock Exchange.</p>\n<p>The shares were bought at prices ranging between HKD 12.67 and HKD 12.88, translating into a volume-weighted average cost of HKD 12.79 per share and an aggregate consideration of HKD 5.09 million.</p>\n<p>After the transaction:\n• Issued shares (excluding treasury shares) declined by 0.0474% to 839.39 million.  \n• Treasury shares increased to 2.16 million, while total issued shares remained unchanged at 841.55 million because the repurchased shares have not been cancelled.</p>\n<p>Repurchase mandate status:\n• The current mandate, approved on 26 May 2026, authorises the repurchase of up to 84.12 million shares.  \n• Including the latest buyback, 1.82 million shares have been repurchased under this mandate, utilising 2.16% of the authorised limit.  \n• In line with listing rules, CONSUN PHARMA is restricted from issuing new shares or disposing of treasury shares until 22 July 2026.</p>\n<p>All repurchases were conducted in compliance with the Main Board Listing Rules, and the company confirmed that all regulatory and corporate approvals were duly obtained.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01681","symbol_name":"康臣药业","start_time":0,"source_url":"","article_id":"1166023004","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1166023004","pubTimestamp":1782129887,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"On 22 June 2026, CONSUN PHARMA executed an on-market repurchase of 398,000 ordinary shares, according to the company’s Next Day Disclosure Return filed with the Hong Kong Stock Exchange. The shares...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01681":"康臣药业"},"translate_title":"康臣药业509万港元回购39.8万股库存股增至216万股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01681":1},"content_text":"On 22 June 2026, CONSUN PHARMA executed an on-market repurchase of 398,000 ordinary shares, according to the company’s Next Day Disclosure Return filed with the Hong Kong Stock Exchange.\nThe shares were bought at prices ranging between HKD 12.67 and HKD 12.88, translating into a volume-weighted average cost of HKD 12.79 per share and an aggregate consideration of HKD 5.09 million.\nAfter the transaction:\n• Issued shares (excluding treasury shares) declined by 0.0474% to 839.39 million.  \n• Treasury shares increased to 2.16 million, while total issued shares remained unchanged at 841.55 million because the repurchased shares have not been cancelled.\nRepurchase mandate status:\n• The current mandate, approved on 26 May 2026, authorises the repurchase of up to 84.12 million shares.  \n• Including the latest buyback, 1.82 million shares have been repurchased under this mandate, utilising 2.16% of the authorised limit.  \n• In line with listing rules, CONSUN PHARMA is restricted from issuing new shares or disposing of treasury shares until 22 July 2026.\nAll repurchases were conducted in compliance with the Main Board Listing Rules, and the company confirmed that all regulatory and corporate approvals were duly obtained.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1166023004","isCrawlerRequest":true}